Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $72.6B |
| FY2017, ended Dec 31, 2017 | $91.7B |
| FY2018, ended Dec 31, 2018 | $74.0B |
| FY2019, ended Dec 31, 2019 | $110B |
| FY2020, ended Dec 31, 2020 | $99.4B |
| FY2021, ended Dec 31, 2021 | $96.8B |
| FY2022, ended Dec 31, 2022 | $124B |
| FY2023, ended Dec 31, 2023 | $110B |
| FY2024, ended Dec 31, 2024 | $114B |
| FY2025, ended Dec 31, 2025 | $111B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $120B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $47.3B |
| FY2017, ended Dec 31, 2017 | $51.0B |
| FY2018, ended Dec 31, 2018 | $53.8B |
| FY2019, ended Dec 31, 2019 | $59.8B |
| FY2020, ended Dec 31, 2020 | $65.4B |
| FY2021, ended Dec 31, 2021 | $67.0B |
| FY2022, ended Dec 31, 2022 | $66.0B |
| FY2023, ended Dec 31, 2023 | $67.6B |
| FY2024, ended Dec 31, 2024 | $71.0B |
| FY2025, ended Dec 31, 2025 | $75.0B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $79.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.17B | $4.13B |
| FY2017, ended Dec 31, 2017 | $1.96B | $5.30B |
| FY2018, ended Dec 31, 2018 | $5.05B | $1.86B |
| FY2019, ended Dec 31, 2019 | $6.23B | $5.83B |
| FY2020, ended Dec 31, 2020 | $6.83B | $6.42B |
| FY2021, ended Dec 31, 2021 | $6.32B | $7.70B |
| FY2022, ended Dec 31, 2022 | $5.73B | $6.13B |
| FY2023, ended Dec 31, 2023 | $6.92B | $6.23B |
| FY2024, ended Dec 31, 2024 | $5.34B | $5.29B |
| FY2025, ended Dec 31, 2025 | $5.02B | $6.91B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $6.51B | $8.38B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.84B |
| FY2017, ended Dec 31, 2017 | $2.86B |
| FY2018, ended Dec 31, 2018 | $772M |
| FY2019, ended Dec 31, 2019 | $1.51B |
| FY2020, ended Dec 31, 2020 | $3.16B |
| FY2021, ended Dec 31, 2021 | $3.60B |
| FY2022, ended Dec 31, 2022 | $2.55B |
| FY2023, ended Dec 31, 2023 | $1.44B |
| FY2024, ended Dec 31, 2024 | $2.48B |
| FY2025, ended Dec 31, 2025 | $4.12B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $5.96B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $14.3B |
| FY2017, ended Dec 31, 2017 | $14.3B |
| FY2018, ended Dec 31, 2018 | $14.7B |
| FY2019, ended Dec 31, 2019 | $12.7B |
| FY2020, ended Dec 31, 2020 | $12.2B |
| FY2021, ended Dec 31, 2021 | $11.7B |
| FY2022, ended Dec 31, 2022 | $15.5B |
| FY2023, ended Dec 31, 2023 | $17.5B |
| FY2024, ended Dec 31, 2024 | $20.3B |
| FY2025, ended Dec 31, 2025 | $21.7B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $20.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 20.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 290M |
| FY2017, ended Dec 31, 2017 | 286M |
| FY2018, ended Dec 31, 2018 | 283M |
| FY2019, ended Dec 31, 2019 | 282M |
| FY2020, ended Dec 31, 2020 | 280M |
| FY2021, ended Dec 31, 2021 | 272M |
| FY2022, ended Dec 31, 2022 | 255M |
| FY2023, ended Dec 31, 2023 | 242M |
| FY2024, ended Dec 31, 2024 | 235M |
| FY2025, ended Dec 31, 2025 | 230M |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | 231M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.10B | $149M |
| FY2017, ended Dec 31, 2017 | $2.00B | $158M |
| FY2018, ended Dec 31, 2018 | $1.49B | $173M |
| FY2019, ended Dec 31, 2019 | $1.20B | $189M |
| FY2020, ended Dec 31, 2020 | $1.10B | $221M |
| FY2021, ended Dec 31, 2021 | $4.09B | $227M |
| FY2022, ended Dec 31, 2022 | $7.90B | $238M |
| FY2023, ended Dec 31, 2023 | $6.00B | $265M |
| FY2024, ended Dec 31, 2024 | $3.70B | $277M |
| FY2025, ended Dec 31, 2025 | $3.00B | $304M |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $750M | $358M |
Valuation
At current price- Market Cap
- $144B
- P/E
- 22.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.8×
- Price / Book
- 14.3×
- EV / EBITDA
- 14.4×
Growth
Trailing 12 months- Revenue (TTM)
- $79.1B
- Revenue Growth YoY
- 7.9%
- Revenue CAGR 3Y
- 4.4%
- Revenue CAGR 5Y
- 2.8%
- EPS Growth YoY
- 56.9%
- Net Income Growth YoY
- 55.1%
Profitability
Trailing 12 months- Gross Margin
- 11.7%
- Operating Margin
- 11.8%
- Net Margin
- 8.2%
- FCF Margin
- 10.6%
- Return on Equity
- 80.2%
Earnings
Trailing 12 months- Net Income
- $6.51B
- EPS (diluted)
- $28.16
- EBITDA
- $11.0B
- Operating Income
- $9.32B
Balance Sheet
As of Sep 27, 2026- Cash and cash equivalents
- $5.96B
- Total Debt
- $20.5B
- Net Debt
- $14.5B
- Total Assets
- $64.5B
- Total Liabilities
- $54.4B
- Shareholders' Equity
- $10.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.1B
- Capital Expenditure
- $1.73B
- Free Cash Flow
- $8.38B
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $13.80
- Beta (5Y)
- 0.09
Every ratio is calculated from the company’s reported figures.